Option Care Health (NASDAQ:OPCH) Updates FY 2026 Earnings Guidance

Option Care Health (NASDAQ:OPCH) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 1.850-1.920 for the period, compared to the consensus EPS estimate of 1.800. The company issued revenue guidance of $5.7 billion-$5.8 billion, compared to the consensus revenue estimate of $5.7 billion.

Wall Street Analysts Forecast Growth

OPCH has been the topic of several recent research reports. Barrington Research lowered their price target on shares of Option Care Health from $42.00 to $32.00 and set an “outperform” rating on the stock in a research note on Friday, May 1st. The Goldman Sachs Group began coverage on shares of Option Care Health in a report on Monday, June 8th. They issued a “neutral” rating and a $22.00 target price on the stock. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $24.00 price target (down from $26.00) on shares of Option Care Health in a report on Thursday. Stephens reiterated an “equal weight” rating and issued a $24.00 price objective (down from $30.00) on shares of Option Care Health in a research note on Friday, July 17th. Finally, JPMorgan Chase & Co. cut their target price on shares of Option Care Health from $40.00 to $33.00 and set an “overweight” rating on the stock in a research report on Monday, May 4th. Seven analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $29.92.

Option Care Health Stock Down 3.4%

NASDAQ OPCH traded down $0.81 during trading hours on Thursday, hitting $23.12. The company’s stock had a trading volume of 2,121,293 shares, compared to its average volume of 2,539,965. The company has a current ratio of 1.64, a quick ratio of 1.07 and a debt-to-equity ratio of 0.85. The company’s 50-day simple moving average is $21.43 and its two-hundred day simple moving average is $26.89. The company has a market capitalization of $3.63 billion, a PE ratio of 17.95, a price-to-earnings-growth ratio of 1.25 and a beta of 0.65. Option Care Health has a 52 week low of $18.01 and a 52 week high of $36.80.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. The company had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.42 billion. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The firm’s revenue was up 1.9% on a year-over-year basis. During the same period last year, the firm earned $0.41 earnings per share. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. Research analysts anticipate that Option Care Health will post 1.64 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CEO John Charles Rademacher purchased 12,500 shares of Option Care Health stock in a transaction that occurred on Monday, May 4th. The stock was bought at an average price of $21.18 per share, for a total transaction of $264,750.00. Following the completion of the transaction, the chief executive officer owned 695,152 shares in the company, valued at $14,723,319.36. This represents a 1.83% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Timothy P. Sullivan acquired 24,154 shares of the firm’s stock in a transaction that occurred on Thursday, May 7th. The shares were bought at an average price of $20.69 per share, with a total value of $499,746.26. Following the acquisition, the director directly owned 73,383 shares of the company’s stock, valued at $1,518,294.27. The trade was a 49.06% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last ninety days, insiders have purchased 73,264 shares of company stock valued at $1,548,316. 1.70% of the stock is owned by insiders.

Key Headlines Impacting Option Care Health

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: Q2 earnings and revenue beat expectations. Option Care reported adjusted earnings of $0.45 per share, above estimates ranging from $0.42 to $0.43 and up from $0.41 a year earlier. Revenue reached $1.44 billion, exceeding the $1.42 billion consensus and increasing 1.9% year over year. Option Care Health Announces Financial Results for the Second Quarter
• Positive Sentiment: Full-year EPS guidance was raised above analyst expectations. Management guided to fiscal 2026 earnings of $1.85-$1.92 per share, compared with the $1.80 consensus estimate. Revenue guidance of $5.7-$5.8 billion was broadly in line with expectations, supporting the earnings outlook. Option Care Beats Q2 Earnings and Revenue Estimates
• Positive Sentiment: The earnings call reinforced the favorable results. Coverage highlighted stronger-than-expected sales and earnings, which helped drive the stock’s initial positive reaction. Option Care Health Q2 2026 Earnings Call Highlights
• Neutral Sentiment: Despite the earnings beat, quarterly revenue growth was relatively modest at 1.9%, and management’s revenue outlook was only consistent with the existing consensus. That may limit upside for investors focused on accelerating growth. Option Care Q2 Earnings Snapshot

Institutional Investors Weigh In On Option Care Health

Large investors have recently added to or reduced their stakes in the company. Durable Capital Partners LP boosted its position in Option Care Health by 134.2% during the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after purchasing an additional 4,720,988 shares during the period. Fuller & Thaler Asset Management Inc. lifted its stake in shares of Option Care Health by 12.1% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 6,958,800 shares of the company’s stock valued at $221,707,000 after buying an additional 752,058 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in Option Care Health by 17.3% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 4,001,307 shares of the company’s stock worth $111,076,000 after buying an additional 590,913 shares during the period. Dimensional Fund Advisors LP grew its stake in Option Care Health by 1.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,840,648 shares of the company’s stock valued at $122,367,000 after buying an additional 44,252 shares in the last quarter. Finally, Morgan Stanley lifted its position in shares of Option Care Health by 13.3% during the fourth quarter. Morgan Stanley now owns 3,410,233 shares of the company’s stock worth $108,650,000 after acquiring an additional 400,740 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.